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Calcium channel blockers and beta-receptor blockers 
improve symptoms of myocardial ischemia by potentially 
different mechanisms. Accordingly, combination ther•
apy may entail additive benefits. Twenty-four patients 
with symptomatic stable effort angina despite full beta•
blockade were randomized to a double-blind Latin square 
protocol in which they received propranolol in a dose 
producing full beta-receptor blockade, diItiazem, 240 
mg/day, in divided doses and a combination of pro•
pranolol and diltiazem, 240 or 360 mg/day. Treadmill 
testing (Bruce protocol) was utilized to assess exercise 
tolerance, radionuclide ventriculography to assess left 
ventricular function and clinical follow-up to assess ad•
verse effects and overall clinical response. 
Comparable treadmill exercise times were observed 
with monotherapy (344 ± 83 seconds with propranolol 
and 341 ± 87 seconds with diltiazem) and the lower dose 
combination (361 ± 87 seconds). With propranolol and 
diltiazem, 360 mg/day, however, there was a significant 
increase in treadmill time (393 ± 106 seconds; p < 0.05). 
In five patients whose treadmill exercise was limited by 
angina on all therapies, there was a significant improve•
ment in the time to onset of chest pain with both low 
Continuing and limiting angina of effort despite adequate 
beta-receptor blockade is a common clinical problem, The 
calcium channel blocking agents are a new class of thera•
peutic alternatives. Diltiazem, a relatively new member of 
this class, has been shown to prevent anginal symptoms and 
improve exercise tolerance in patients with coronary artery 
From the Cardiac InvesligatJOn Umt. UmvefSlty HosPJtal, London, 
Dntano, Canada. This study wa; supported in part by The Dntano Heart 
and Stroke Foundation, Toronto, Dnlano. Canada and NordiC Laboralone" 
Montreal, Quebec. Canada. 
*Present address Division of Cardiology, UmverMty of Alberta, Hos•
pital, Edmonton, Alberta, Canada. 
Manuscript received April 8, 1985; revI;ed manuscnpt received June 
18. 1985, accepted September 18. 1985. 
Address for reprint;: William J Km,tuk. MD. Cardiac Invesligation 
Unit, University Hospital, Box 5339. Termmal A. London. Dntano. N6A 
5A5 Canada. 
© 1986 by the Amencan College of CardlOlog} 
dose and high dose combinations (311 ± 71 seconds, 
p < 0.05 and 336 ± 76 seconds, p < 0.01, respectively). 
Improved treadmill performance was supported by the 
clinical response, while an increase in adverse effects 
was not observed. Thirteen of 24 patients blindly selected 
the higher dose diltiazem combination as their optimal 
therapy. 
Left ventricular dilation was observed (by radio•
nuclide ventriculography) in response to exercise in each 
phase of therapy; this was related to stress-induced isch•
emia. Cardiac index was higher at rest (3.2 ± 0.6 
liters/min per m2) and during exercise (5.5 ± 1.2 
liters/min per m2) with diItiazem therapy in relation to 
an increased heart rate (rest 66 ± 8 beats/min, exercise 
95 ± 10). 
Combination therapy of propranolol and diltiazem 
(particularly with the higher diltiazem dose of 360 mg/day) 
results in significant improvement in exercise capacity 
and reduction in symptoms without an increase in ad•
verse effects or sigqificant deterioration of left ventric•
ular function in patients who have continued symptoms 
of angina on monotherapy alone. 
(J Am Coll CardioI1986;7:329-35) 
disease ( I ,2). This anti anginal effect is thought to be related 
to an increase in coronary and subendocardial blood flow 
(3,4). Thus, calcium channel blockers appear to alleviate 
angina by different mechanisms from those of beta-blockers 
(5). Consequently, the potential for additional anginal relief 
with improved exercise tolerance might be possible with 
combination therapy. 
In this study. the clinical efficacy of diltiazem alone and 
in combination with propranolol was evaluated in a group 
of patients who continued to be limited by exertional angina 
despite beta-blockade. The purpose of the study was two•
fold: I) to determine whether an alternative form of therapy 
or combination therapy would be indicated; and 2) if com•
bination therapy is effective. to determine whether there is 
any dose-related increase in adverse effects or impairment 
of left ventricular function. 
0735-1097/86/$3 50 
330 HUMEN ET AL 
COMBINED CALCIUM AND BETA-BLOCKER THERAPY 
Methods 
Study patients. Patients with a history of stable exer•
tional angina with treadmill stress tests limited by angina 
and associated with I mm or greater horizontal or down•
sloping ST segment depression in the presence of adequate 
beta-receptor blockade were candidates for entry to the study. 
Full beta-blockade was defined as a maximal h~art rate of 
less than 120 beats/min during stress testing and a propran•
olol dosage of at least 160 mg/day in divided doses. Patients 
with unstable angina, heart failure, cardiac rhythm distur•
bances or myocardial infarction within the past 3 months 
were excluded. All cardiac medications except propranolol 
were withdrawn for at least I week before patients entered 
the study. 
Twentyjour patients were entered in the study. During 
the course of investigation, one patient died from myocardial 
infarction and one was withdrawn because of an intercurrent 
gastrointestinal illness. These patients were replaced in the 
protocol by two others. The final study group consisted of 
19 men and 5 women with a mean age of 57 years (range 
37 to 71). Eight patients had previous myocardial infarction 
and 19 patients had coronary angiography that demonstrated 
single, double and triple vessel disease in 5,7 and 7 patients, 
respectively. All patients gave informed consent for this 
study, which was approved by the Health Sciences Standing 
Committee on Human Research of The University of West•
ern Ontario. 
Study design. Patients were randomized blindly to a 
6 x 4 Latin square with 2 week treatment regimens con•
sisting of propranolol in a dose sufficient to provide full 
beta-blockade, diltiazem 240 mg/day in divided doses, pro•
pranolol plus diltiazem 240 mg/day and propranolol plus 
diltiazem 360 mg/day in diVided doses. Identical placebo 
tablets for propranolol and diltiazem were utilized so that 
all treatment protocols appeared identical to both the patient 
and physician. 
Exercise testing. Patients underwent graded treadmill 
exercise testing (Bruce protocol) before entry into the pro•
tocol and at the end of each treatment period. Heart rate, 
Table 1. Adverse Effects in 24 Patients 
P D PD-I PD-2 
Faugue 8 4 8 7 
Dyspnea 2 2 4 2 
Cold limb, 2 
Sleep disturbance 2 2 
Edema 2 
Headache 4 
Depression 3 
Ga,tromtestinal upset 2 2 
D = diltiazem, 240 mg/day; P = propranolol, mean do;e 170 mg/day; 
PD-I = propranolol plus dilUazem, 240 mg/day; PD-2 = propranolol 
plus dlltiazem, 360 mg/day. 
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Table 2, Clit1Ical Re'pom,e to Therapy in 2--1- Paticnb 
P D PD-I PD-:2 
Frequency of 75 ± 7.2 100 ± 14 5. I ± 7.4*+ 3 H ± -+ -+t:j: 
angina 
(no./week) 
Nltroglycerm 7.9 ± 5.8 6.8 ± 12.5 4.3 ± I 0* :2 5 ± 4.M 
use 
(no./week) 
Patient 3 3 .5 13 
preference 
*p < 0 05 ver,u; propranolol; tp < 0.0 I ver,us propranolol; :j:p < 
0.01 versu; diltIazem. §p < 0.05 versw, dlltiazem; value, are mean ± 
SD. AbbreViatIOn, as m Table I. 
blood pressure and a 12 lead electrocardiogram were re•
corded at the end of each stage, with the onset of chest 
discomfort, at peak exercise and every 2 minutes for 6 
minutes into the recovery period. The PR interval, heart 
rate and extent of ST segment depression were measured 
from the electrocardiogram. 
Radionuclide ventriculography. In vitro labeling of 
the patient's red blood cells was performed using 25 mCi 
oftechnetium-99m pertechnetate. Two minute gated images 
utilizing 16 frames per cardiac cycle were acquired at rest 
and at supine cycle exercise consisting of 3 minute stages 
of 25 W increments. Left ventricular end-diastolic end•
systolic and background regions of interest were-deter:nined 
manually in duplicate for calculation of ejection fraction. 
A calibrated, nongeometric method of determining left ven•
tricular end-diastolic and end-systolic volumes was utilized 
(r = 0.985, SEE 3 ml versus contrast left ventriculography) 
from which the stroke volume and cardiac output were de•
rived (6). 
Statistical analysis. Paired two-tailed t test and two•
way analysis of variance were used to determine statistical 
significance at or in response to exercise where appropriate. 
Results 
Adverse effects (Table 1). In the course of study, re•
ported adverse effects were relatively common; these were 
often mild, well tolerated and did not cause premature ad•
vancement from the treatment period or withdrawal from 
the trial. The feeling of fatigue was less frequent when 
patients were receiving diltiazem monotherapy than when 
they were treated with propranolol alone or in combination. 
Sensation of headache or depression appeared to be 'slightly 
more frequent in patients treated with diltiazem alone and 
was associated with a slight increase in frequency of angina 
of effort and nitroglycerin use. 
Frequency of angina and nitroglycerin use (Table 
2). Patients maintained a diary during each treatment pe•
riod, recording each instance of angina and nitroglycerin 
lACC Vol 7. No 2 
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Table 3. Results of Treadmill Exercise Testing in 24 Patients 
Treadmill lime (~econd~) 
Time to pain (second,) 
Limitation by angina (no, pb.) 
Llmllation by fallgue (no. pts ) 
Treadmill time (angina) (n = 5) 
(seconds)~ 
Time to pain (n = 5) (second~)~ 
Heart rate (beats/min) 
Rest 
Exercise 
P 
344 ± 83 
242 ± 55 
18 
6 
307 ± 53 
242 ± 55 
58 ± 7+ 
95 ± 10:1: 
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D 
341 ± X7 
278 ± 61 
19 
5 
338 ± 76 
278 ± 61 
66 ± 6 
113 ± 12 
PD-I 
361 ± 87 
311 ± 71* 
IS 
6 
347 ± 79 
311 ± 71* 
54 ± 6:1: 
90 ± IU 
PD-2 
393 ± 106*t 
336 ± 77<t 
6 
18 
390 ± 71*t 
336 ± 76*+ 
54 ± 8+ 
89 ± 13*:1: 
331 
Rate-pre~sure product (mm Hg/nun) 
Rest 
ExerCise 
7.370 ± l.220t 
12.700 ± 2.730:1: 
8.690 ± 1,480 
17.080 ± 3,420 
6.770 ± 1,060t 
12.200 ± 2,340+ 
6,540 ± I, 152t 
11,790 ± 2,700*:1: 
ST segment depressIOn (mm) 
Rest -027 ± 0.36 -0.34 ± 045 -029 ± 0.36 -0 II ± 0.31§11 
ExerCl,e -163 ± 097 -I 53 ± 0.84 -1.51±072 - I 30 ± 0.78*t§ 
PR Interval (ms) 
Rest 
Exercl~e 
165 ± 27 
161 ± 23 
158 ± 14*§ 
152 ± 1711 
168 ± 23t 
158 ± 23 
178 ± 2U§ 
164 ± 26§ 
*p < 0.05 versus propranolol; tp < 0 05 versu~ dilllazem.:j:p < 0.01 ver~us dlltiazem; §p < 0.05 versus PD-l.llp < 0 01 versus propranolol; ~Ithe,e 
were five patients who continued to be limited by angina dunng each treatment penod. Values are mean ± SD pts = patients; other abbrevlatlOm, a~ 
in Table I 
use for relief of chest discomfort. Low or high dose com•
bination therapy was associated with fewer episodes of effort 
angina and less nitroglycerin use compared with either form 
of monotherapy. Frequency of chest pain and nitroglycerin 
use were slightly higher with diitiazem than with propranolol 
and with the low dose than with the high dose combination. 
There was no statistical difference between the two com•
binations or between the two monotherapies. Patients re•
ceiving either form of combination therapy. however. showed 
Figure 1. Total treadmill time (dotted bars) is increased With 
less ST segment depression (crosshatched bars) With high dose 
combination therapy (PD-2) compared with propranolol (P) or 
diltiazem (D) monotherapy. Height of bar represents mean ± SO. 
o = diltiazem (240 mg/day); PD-l = propranolol plus diltiazem 
(240 mg/day); PD-2 = propranolol plus diltiazem (360 mg/day); 
*p < 0.05 versus propranolol; + p < 0.05 versus diltiazem. 
Sec 
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a significant improvement in anginal relief and nitroglycerin 
use compared with monotherapy. At the conclusion of the 
study and before the therapeutic codes were broken. the 
majority of patients (18 of 24) selected either the low dose 
(5 patients) or high dose (13 patients) propranolol plus dil•
tiazem combination as the therapy of choice. 
Treadmill exercise tests (Table 3). Total exercise du•
ration and the time to onset of chest pain were sitnilar for 
both forms of monotherapy and for low dose combination 
Figure 2. In the five patients whose treadmill exercise wa~ lImited 
by angina during each therapy, both treadmill time (dotted bars) 
and time to pain (crosshatched bars) were improved with the 
combination therapies compared with monotherapy alone. Addi•
tional improvement was attained with the higher dose combination. 
*p < 0.05 versus propranolol; + p < 0.05 versUs diltiazem; + + P 
< 0.01 versus diltiazem; n = 5. Abbreviations as in Figure 1. 
Sec 
~~-----------------------, 
400 
300 
200 
100 
P D PD-l PD-2 
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therapy. With the higher dose combination therapy, there 
was a significant increase in both treadmill time and time 
to onset of pain (Fig. 1). Only 5 of the 24 patients continued 
to be limited by angina during each treatment period. In 
this small subgroup, the pattern was slightly different. With 
monotherapy, treadmill times were comparable, whereas 
with each combination therapy there was further significant 
improvement in treadmill time and time to pain (Fig. 2). 
Despite entry criteria that dictated that effort angina must 
be present in the face of adequate beta-blockade, 25% of 
the patients were no longer limited by angina, despite re•
ceiving identical therapy during the double-blind phase of 
the study. This decrease in exercise-induced angina was 
similar with diltiazem alone or with lower dose combination 
therapy. However, with the higher dose combination 75% 
of the patients stopped treadmill exercise because of fatigue 
and dyspnea rather than angina. 
During exercise, the heart rate-systolic blood pressure 
(rate-pressure) product was significantly higher with dilti•
azem therapy. The rate-pressure product was similarly de•
creased with the lower combination therapy and propranolol 
therapy both at rest and at peak exercise. Further reduction 
in rate-pressure product during exercise occurred with the 
high dose combination therapy. This decrease was mediated 
largely by similar reductions in the heart rate response sec•
ondary to the beta-blockade. 
Exercise was associated with comparable ST segment 
depression at peak stress with both forms of monotherapy 
and with the lower dose combination. The extent of ST 
segment depression was less with the higher dose combi•
nation at peak exercise (Fig. 1). 
Table 4. Results of Radionuclide Ventriculography in 24 Patients 
P 
EDVI (ml/m2) 
Rest 102 ± 27 
Exercise III ± 2911 
ESVI (mllm2) 
Rest 46 ± 18 
Exercise 51 ± 2011 
SVI (mllm2) 
Rest 56 ± II 
Exercise 60 ± 12§ 
Heart rate (beats/min) 
Rest 59 ± 11+ 
Exercise 83 ± 11+ 
EjectIOn fraction (%) 
Rest 57 ± 9 
Exercise 56 ± 9 
Cardiac index (liters/min per m2) 
Rest 3.0 ± 0.6t 
Exercise 4.6 ± 0.8+ 
lACC Vol 7. No.2 
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Atrioventricular (A V) conduction, as reflected by the PR 
interval, was significantly prolonged with the higher dose 
combination therapy. The difference was not as marked with 
exercise. No episodes of second or third degree heart block 
were observed. 
Radionuclide ventriculography (Table 4, Fig. 3). 
Patients admitted to the study had no clinical evidence or 
history of heart failure in the face of full beta-blockade. By 
design, then, all patients had normal or near normal left 
ventricular function at rest. 
At rest, left ventricular ejection fraction was slightly higher 
with both combination treatments compared with either form 
of monotherapy. Although left ventricular volumes-both 
end-systolic (Fig. 3c) and end-diastolic (Fig. 3a)-were 
similar with all treatments, the end-diastolic volume tended 
to be slightly smaller during diltiazem therapy. Conse•
quently, the derived stroke volume calculation was similar 
with diltiazem monotherapy (Fig. 3b). Cardiac index, on 
the other hand, was significantly higher during diltiazem 
therapy secondary to a higher heart rate at rest (Fig. 3d). 
With exercise, the left ventricular end-diastolic and end•
systolic volumes (Fig. 3a,c) increased in a similar manner 
during each treatment type. Stroke volume also increased 
with all treatment modalities but to a slightly greater extent 
with combination therapy than with propranolol alone (Fig. 
3b). As a result of the volume changes, ejection fraction 
was slightly higher at exercise with diltiazem and both com•
binations than with propranolol. Finally, as a result of the 
higher exercise heart rate with diltiazem therapy, cardiac 
index was higher than with other treatment modalities, which 
were similar to each other. 
D PD-I PD-2 
96 ± 27 100 ± 22 102 ± 27 
III ± 3311 114 ± 3111 115 ± 31 
43 ± 16 43 ± 15 43 ± 16 
49 ± 23§ 48 ± 1811 50 ± 2011 
53 ± 13 57 ± lit 57 ± 13t 
62 ± 1411 66 ± 18*11 66 ± 17*11 
66 ± 8 55 ± 7*+ 54 ± 8*+ 
95 ± 10 79 ± 9+ 80 ± 13*+ 
57 ± 7 59 ± 7*t 59 ± 7*t 
58 ± 10* 59 ± 8* 58 ± 9* 
3.2 ± 0.6 2.9 ± 0.6t 3.0 ± 0.6t 
5.5 ± 1.2 4.9 ± l.4t 5.0 ± 1.8t 
*p < 005 versus propranolol; tp < 0.05 versus diltiazem; :j:p < 0.01 versus diluazem; §p < 0.05 versus rest; lip < 0.01 versus rest. Values are 
mean ± SD. EDVI = end-diastolic volume mdex; ESVI = end-systolic volume index; SVI = stroke volume mdex, other abbreVIations as in Table I. 
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Discussion 
Clinical efficacy. Previous studies have clearly dem•
onstrated that as monotherapy, diltiazem is an effective an•
tianginal agent at a dose of 240 mg/day (I) with some 
additional apparent improvement at 360 mg/day (7,8). Hung 
et al. (7) assessed exercise performance using combination 
propranolol and diltiazem therapy. Although. unlike our 
study, they did not demonstrate an increased exercise tol•
erance using combination therapy compared with single agent 
therapy, they did observe similar efficacy of the combination 
in suppressing exercise-induced symptoms of angina asso•
ciated with a decrease in ST segment depression. In our 
study group, results of combination therapy with lower dose 
diltiazem were no different from those of either propranolol 
or diltiazem alone at the same dosage with regard to total 
treadmill time, anginal frequency, nitroglycerin use or ad•
verse effect. With the higher dose diltiazem-propranolol 
combination, there was significant subjective and objective 
improvement in each of these variables without any increase 
in adverse effects. This was also reflected by the patients' 
own preferences for this therapy. Furthermore, in the subgroup 
of five patients who continued to be limited by angina on 
the treadmill, the superiority of the higher dose combination 
was maintained. Again, this improvement occurred without 
any increase in adverse effects. 
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Figure 3. The left ventncular volume response for each therapy 
is shown both at rest (R) and dunng exercise (Ex). End-diastolic 
volume (a) and end-systolic volume (e) increased with exercise as 
a mamfestation of stress-induced left ventricular dysfunction sec•
ondary to ischemia. Stroke volume (b) improved with exercise to 
a greater extent with combination therapy compared with pro•
pranolol. Cardiac index (d) was higher at rest and exercise with 
diltiazem. secondary to a higher heart rate. *p < 0.05 versus 
diltiazem: +p < 0.05 versus propranolol: **p < 0.01 versus 
diltiazem: + +p < 0.01 versus rest; #p < 0.05 versus rest. Ab•
breviations as in Figure 1. 
Individual variability. Although the entry criteria for 
this study necessitated that patients have angina during 
treadmill exercise while receiving beta-blocker therapy, 25% 
of patients during the double-blind phase were limited only 
by fatigue on treadmill testing while receiving identical ther•
apy (propranolol). In addition to placebo effect, this finding 
reflects the individual variability of patients with angina as 
recently addressed by Starling et al. (9). They observed a 
large variability in treadmill times with sequential testing, 
although the rate-pressure product remained relatively con•
sistent at peak exercise. Starling et al. also observed a 10% 
spontaneous remission of exercise-induced angina during 
the course of a single day. This individual variability appears 
to account for some remission in effort angina. Neverthe-
334 HUMEN ET AL 
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less, despite these individual variabilities, the group means 
for treadmill time remain consistent (9,10). 
Myocardial performance. Although no patient with se•
rious left ventricular dysfunction was included in this study, 
and although monotherapy with diltiazem and propranolol 
has only minor negative inotropic effects, potential deteri•
oration of left ventricular function with the combination is 
of concern. In our study, the alteration in left ventricular 
function observed during rest and exercise was similar ir•
respective of the therapeutic regimen. During supine ex•
ercise, there was dilation of the heart with an increase in 
both end-diastolic and end-systolic volumes. Consequently, 
there was a slight but statistically significant increase in 
ejection fraction both at rest and during exercise with each 
combination therapy. While this increase is of no clinical 
significance, the important physiologic interpretation of this 
observation is the lack of deterioration in left ventricular 
function with combination therapy, although this may not 
apply to patients with serious left ventricular dysfunction. 
The alterations observed in stroke volume and cardiac index 
are a reflection of the summation of effects on end-diastolic 
volume and heart rate. With diltiazem alone, the rest and 
peak exercise heart rates are higher than those seen with 
propranolol alone or combination therapy. Consequently, 
the diastolic filling period would be reduced, leading to a 
small decrease in end-diastolic volume and stroke volume. 
This difference in heart rate is associated with a significantly 
higher cardiac index with diltiazem therapy. 
Mechanism of angina reduction. A different mecha•
nism of action for propranolol and diltiazem is reflected by 
the significantly different heart rate and rate-pressure prod•
uct in the setting of comparable treadmill times and extent 
of ST segment depression. With combination therapy, how•
ever, the anti-ischemic action appears to be dependent mainly 
on the rate-pressure product, suggesting counterbalancing 
effects from each drug. It would appear that the lower dose 
combination therapy provides little advantage over mono•
therapy. One might speculate that beta-blocker therapy in•
terferes with improvement in collateral and subendocardial 
blood flow afforded by the addition of the lower dose of 
diltiazem. This effect may be partially overcome by a higher 
dose of diltiazem resulting in improvement in anginal pro•
phylaxis which is associated with improvement in treadmill 
exercise duration and reduction in ST segment depression 
at peak exercise despite a similar rate-pressure product. The 
magnitude of the interaction appears heavily weighted in 
the direction of the effects of beta-blockade. Even with the 
higher dose diltiazem combination, the extent of ST segment 
depression is more closely associated with an altered rate•
pressure product, similar to that seen with propranolol alone 
or in combination with diltiazem given at the lower dose. 
Hung et al. (7) made similar observations and showed that 
diltiazem given at 360 mg/day in divided doses was com•
parable with a similar combination of propranolol and dil-
lACC Vol 7. No.2 
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tiazem for the relief of angina and improvement in exercise 
tolerance. 
When the therapeutic intervention suppresses the target 
symptoms, problems arise with group analysis. In the study 
of Hung et al. (7), 12 patients had effort angina, of whom 
II had associated diagnostic ST segment shift. With pro•
pranolol therapy alone these investigators were left with only 
eight patients with exercise-induced angina with a further 
reduction to six with diltiazem alone or combination ther•
apy. Thus, group analysis includes a significant proportion 
of patients who were now angina-free and may be limited 
in their exercise performance by symptoms unrelated to their 
heart disease. Further, the failure to demonstrate a difference 
in a small group of patients may reflect a type II statistical 
error. The same difficulties arise in analysis of our entire 
patient group. However, when only the patients who were 
limited by exercise angina with each therapeutic intervention 
are considered, there is clear benefit with each combination 
therapy over monotherapy with respect to both total tread•
mill time and time to onset of pain (Fig. 2). 
Conclusions. Anginal symptoms may regress sponta•
neously during the course of I month in a significant number 
of patients if therapy is left unchanged. In patients who 
continue to be limited by angina despite adequate beta•
blockade, further alleviation of symptoms and increase in 
exercise capacity may be observed with the addition of 
diltiazem. A higher dose of diltiazem (360 mg/day) is more 
effective in combination with propranolol than a lower dose 
(240 mg/day) for anginal prophylaxis. Of considerable im•
portance is the lack of any deleterious effect on left ven•
tricular function or of increased adverse clinical effects with 
such combination therapy. Moreover, in patients who ex•
perience adverse effects of fatigue, lassitude or troublesome 
dreams while receiving propranolol therapy alone, diltiazem 
as a single agent therapy can provide identical anginal pro•
phylaxis without the adverse effects. 
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